Emergent Biosolutions Snags Upgrade After FDA Approves OTC Narcan
The biotech plans to launch the over-the-counter product this summer, beating competitors to the punch.
Stay updated with breaking news from Robert Wasserman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotech plans to launch the over-the-counter product this summer, beating competitors to the punch.
The U.S. Food and Drug Administration on Wednesday approved over-the-counter (OTC) sales of Emergent BioSolutions Inc's Narcan, allowing for easier availability of the life-saving medication used to reverse opioid overdoses.
"For people who need it most, it needs to be at a lower price point than what it is currently available," said Maryann Mason, associate professor of emergency medicine at Northwestern University.
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved using Emergent BioSolutions Inc's Narcan without a prescription, paving the way...
The U.S. Food and Drug Administration on Wednesday approved over-the-counter (OTC) sales of Emergent BioSolutions Inc's Narcan, allowing for easier availability of the life-saving medication used to